These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 11363839

  • 1. Delavirdine/protease inhibitor interactions.
    Gilden D.
    GMHC Treat Issues; 1996 Sep; 10(9):11-2. PubMed ID: 11363839
    [Abstract] [Full Text] [Related]

  • 2. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [Abstract] [Full Text] [Related]

  • 3. Delavirdine dilemma at the FDA. Food and Drug Administration.
    Smart T.
    GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
    [Abstract] [Full Text] [Related]

  • 4. Delavirdine gets the green light.
    Vazquez E.
    Posit Aware; 1997 Dec; 8(3):18-9. PubMed ID: 11364419
    [Abstract] [Full Text] [Related]

  • 5. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [Abstract] [Full Text] [Related]

  • 6. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M.
    AIDS Treat News; 1996 Dec 06; (No 260):3-5. PubMed ID: 11364022
    [Abstract] [Full Text] [Related]

  • 7. Delavirdine gains approval as second NNRTI for anti-HIV combination regimens.
    Crit Path AIDS Proj; 1997 Dec 06; (No 32):29-30. PubMed ID: 11364439
    [Abstract] [Full Text] [Related]

  • 8. Delavirdine data: skewed or skewered?
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1997 Feb 06; 3(2):42-6. PubMed ID: 11364099
    [Abstract] [Full Text] [Related]

  • 9. '96-'97 new drugs and the nominees for 1997 are...
    Notes Undergr; 1997 Feb 06; (No 35):suppl 1-2. PubMed ID: 11364566
    [Abstract] [Full Text] [Related]

  • 10. [New combination medications].
    Agosto M.
    Sidahora; 1997 Feb 06; ():43-6. PubMed ID: 11364501
    [Abstract] [Full Text] [Related]

  • 11. Delavirdine (Rescriptor) approved.
    James JS.
    AIDS Treat News; 1997 Apr 18; (No 269):1-3. PubMed ID: 11364252
    [Abstract] [Full Text] [Related]

  • 12. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M.
    BETA; 1996 Jun 18; ():19-22. PubMed ID: 11363645
    [Abstract] [Full Text] [Related]

  • 13. Now there are eleven, but so what?
    Gilden D.
    GMHC Treat Issues; 1997 Jun 18; 11(4/5):1-3. PubMed ID: 11364371
    [Abstract] [Full Text] [Related]

  • 14. Expanded access for delavirdine.
    Posit Aware; 1996 Jun 18; 7(3):5-6. PubMed ID: 11363426
    [Abstract] [Full Text] [Related]

  • 15. A new class of anti-HIV drugs.
    Treat Rev; 1996 Aug 18; (No 22):8-9. PubMed ID: 11363816
    [Abstract] [Full Text] [Related]

  • 16. Antiviral update.
    PI Perspect; 1996 Nov 18; (No 20):8-9. PubMed ID: 11363972
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of antiretroviral drugs.
    Hoetelmans RM.
    Antivir Ther; 1999 Nov 18; 4 Suppl 3():29-41. PubMed ID: 16021869
    [Abstract] [Full Text] [Related]

  • 18. Delavirdine expanded access program.
    BETA; 1996 Jun 18; ():7. PubMed ID: 11363651
    [Abstract] [Full Text] [Related]

  • 19. Efavirenz's complications.
    GMHC Treat Issues; 1998 May 18; 12(5):6. PubMed ID: 11365477
    [Abstract] [Full Text] [Related]

  • 20. Delavirdine levels in women.
    Vazquez E.
    Posit Aware; 1997 May 18; 8(4):14. PubMed ID: 11364481
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.